Related Experiment Videos
Effect of melatonin on intraocular pressure
J R Samples1, G Krause, A J Lewy
1Department of Ophthalmology, Oregon Health Sciences University, Portland 97201.
Current Eye Research
|July 1, 1988
Summary
Melatonin, a hormone, was found to lower intraocular pressure in humans. This study suggests melatonin may be a safe and effective treatment for eye pressure management.
Area of Science:
- Ophthalmology
- Endocrinology
- Pharmacology
Background:
- Intraocular pressure (IOP) is a key factor in glaucoma pathogenesis.
- Melatonin, a hormone regulating sleep-wake cycles, has shown potential ocular effects.
- Understanding melatonin's role in IOP could reveal new therapeutic targets.
Purpose of the Study:
- To investigate the effect of oral melatonin administration on human intraocular pressure.
- To determine if melatonin can modulate IOP in a controlled experimental setting.
Main Methods:
- Oral melatonin was administered to human subjects.
- Serum melatonin levels were suppressed using bright light exposure to create a controlled condition.
- Intraocular pressure was measured before and after interventions.
Main Results:
- Oral melatonin administration was associated with a reduction in intraocular pressure.
- Suppression of endogenous melatonin by bright light provided a comparative baseline.
- Melatonin demonstrated efficacy in lowering IOP in the studied population.
Conclusions:
- Melatonin effectively lowers intraocular pressure in humans.
- Melatonin may represent a novel, safe, and effective therapeutic agent for managing elevated IOP.
- Further research into melatonin's ocular applications is warranted.